about
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the HeartPRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ CostimulationCXCL10 Acts as a Bifunctional Antimicrobial Molecule against Bacillus anthracis.Salmonella Suppresses the TRIF-Dependent Type I Interferon Response in Macrophages.Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's diseaseBacterial Autophagy: Offense and Defense at the Host-Pathogen Interface.Hhip haploinsufficiency sensitizes mice to age-related emphysemaMolecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions.Informatics-Based Discovery of Disease-Associated Immune Profiles.Chemokine Levels in the Penile Coronal Sulcus Correlate with HIV-1 Acquisition and Are Reduced by Male Circumcision in Rakai, Uganda.Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis.Blocking CXCL9 Decreases HIV-1 Replication and Enhances the Activity of Prophylactic Antiretrovirals in Human Cervical Tissues.Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studiesElevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.Qingchang Wenzhong Decoction Ameliorates Dextran Sulphate Sodium-Induced Ulcerative Colitis in Rats by Downregulating the IP10/CXCR3 Axis-Mediated Inflammatory Response.Synergistic Communication between CD4+ T Cells and Monocytes Impacts the Cytokine Environment.CXCL9: evidence and contradictions for its role in tumor progression.CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction.Teleost Chemokines and Their Receptors.Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma.ZNF395 Is an Activator of a Subset of IFN-Stimulated Genes.Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice.Pancreatic islet inflammation: an emerging role for chemokines.Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.CXCL9, a promising biomarker in the diagnosis of chronic Q fever.Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2.Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection.Allergic Contact Dermatitis: A Model of Inflammatory Itch and Pain in Human and Mouse.Chemokine Signaling during Midline Epithelial Seam Disintegration Facilitates Palatal Fusion.CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.Cigarette Smoke Exposure Worsens Endotoxin-Induced Lung Injury and Pulmonary Edema in Mice.Chemokines from a Structural Perspective.Maternal Adaptive Immune Cells in Decidua Parietalis Display a More Activated and Coinhibitory Phenotype Compared to Decidua Basalis.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.Prime and Boost Vaccination Elicit a Distinct Innate Myeloid Cell Immune Response.Pathology after Chlamydia trachomatis infection is driven by nonprotective immune cells that are distinct from protective populations.
P2860
Q28079006-9A6C0F52-BD58-44E3-91BD-7FBEF0C72D1AQ28550383-B6B1069A-52BA-4B1A-9925-C0B5231B6910Q30276830-EFEF7A4E-B995-4318-BD16-9C43EDF6CE83Q30277329-15351DBC-BDEB-41A1-BED9-C7D42A98E948Q33594698-A8B380D6-435F-4490-A98B-BA6426A1013EQ33824141-8229F4E3-219F-4BE2-BF94-9DC2387DD9D9Q34534888-659F7976-DFC2-4C20-894B-F41DB0B73ABEQ35723326-C2553E3E-94D2-45FA-896D-185152DAB58DQ36144937-69DD885E-E124-4161-ADF2-EDD14766CA0CQ36206911-DC9E5ADE-87AC-49B5-8BD9-12BCA37CA826Q36266655-1E8CB91D-D2AE-4F10-9E05-4A8C40FF16C8Q36678079-260F508C-018A-4AE0-8F09-45CC217FD50BQ36955998-8DBF50DD-7683-4923-A0CA-934604602011Q37046500-D2C56E1F-7868-4D96-963B-D55F78D342CFQ37054120-2D26407A-4DD4-4B4A-B540-823620760F99Q37323854-C6A81B97-3771-411F-8C5B-B1F20B59145EQ37429985-1EF2B6E8-BCAC-4AD5-9A4F-FDCD2AF76F16Q37526953-A669DF14-EF12-448C-8211-D2EED31569B7Q38633820-286E7884-58A7-4792-ABF8-13C1C72AC962Q38681182-DEFA399E-4DDB-4A79-A25B-B2FE7430AFBBQ38694064-48C93F80-D2E0-43E6-951A-3C463F3B1AC7Q38711612-47E1B44A-C29C-41D5-9C1A-685EF4CDCA72Q38841148-E714C2FE-8550-4060-B037-5991369FFF78Q39249398-A5D7D4E9-FC66-4F84-B8E4-4BFECFC110FEQ39901834-C97C5055-3286-45E0-AC90-C2ECCF1FF295Q40042419-67CE0588-351B-4505-9E18-7314ED51C340Q40043965-3DAA7085-7455-4920-B62B-DE7C2FDE2BCFQ40072169-7F0FD81D-F67A-4A57-AEBC-DCD2E989D78DQ40088561-EB5206A7-D7F3-4ED9-B76D-A0C8DE61E168Q40194358-B8540258-F4E7-4F70-A4B5-6644F94B5E02Q40359006-B92EC59B-6815-4EFD-895C-6424B606EDBDQ41811724-E0830E95-8AAA-4EAB-B4FE-C8B26C9C8A12Q44885716-3F2CE48F-1F84-4540-9835-5E5B449B8AE8Q45263238-27F0267F-3AC9-4596-9F3F-25FD4615186DQ45973061-6B4516AB-9036-4747-AB6A-5D4DCC76CF10Q47154563-363A25EC-8A75-4855-AE97-BB6685052C5EQ47235990-9AFA4085-FFA1-4FD2-98C7-FD2C1F69DF5CQ49524220-DDFC5BFC-1A6F-48EF-96F1-B6C3595DA347Q49958499-CFABD42D-ADF5-4F5B-BC6E-DA3B60DDDE7AQ50026660-96DED032-200E-4DEE-9D19-46846DA3EA2B
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
CXCR3 ligands in disease and therapy.
@en
type
label
CXCR3 ligands in disease and therapy.
@en
prefLabel
CXCR3 ligands in disease and therapy.
@en
P50
P1476
CXCR3 ligands in disease and therapy
@en
P2093
Katrien Van Raemdonck
Sandra Liekens
P304
P356
10.1016/J.CYTOGFR.2014.11.009
P577
2014-11-22T00:00:00Z